Post-COVID-19 endogenous endophthalmitis case series and review of literature.
Journal
Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
received:
22
11
2022
accepted:
01
08
2023
medline:
23
11
2023
pubmed:
22
11
2023
entrez:
22
11
2023
Statut:
ppublish
Résumé
To describe a series of post-coronavirus disease 2019 (COVID-19) endogenous endophthalmitis (EE) patients from a multispecialty tertiary hospital in North India. A retrospective chart review including all consecutive cases with EE following confirmed COVID-19 disease from July 2020 to June 2021. Seven eyes of four patients (three female and one male) were included. Two patients had confirmed bilateral fungal (Aspergillus sp.) EE and two patients had presumed fungal EE (one bilateral and one unilateral). Three of these four patients received systemic steroids as part of COVID-19 treatment previously. Five eyes were managed with initial intravitreal injection (IVI), followed by pars plana vitrectomy (PPV), and two eyes were managed with only IVI. All patients received systemic antifungal agents. Intraocular inflammation resolved in all eyes with treatment. One patient of EE also developed voriconazole-induced transient visual hallucination, which resolved on discontinuing the medication. This case series represents a series of EE cases following COVID-19 disease or its sequelae or as a result of prior treatment for COVID-19. Ophthalmologists and physicians must be vigilant about these complications and initiate prompt management at the earliest.
Identifiants
pubmed: 37991303
doi: 10.4103/IJO.IJO_3079_22
pii: 02223307-202371120-00019
doi:
Substances chimiques
Antifungal Agents
0
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3677-3683Informations de copyright
Copyright © 2023 Copyright: © 2023 Indian Journal of Ophthalmology.
Références
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20.
Zhong Y, Wang K, Zhu Y, Lyu D, Yu Y, Li S, et al. Ocular manifestations in COVID-19 patients: A systematic review and meta-analysis. Travel Med Infect Dis 2021;44:102191.
Bertoli F, Veritti D, Danese C, Samassa F, Sarao V, Rassu N, et al. Ocular findings in COVID-19 patients: A review of direct manifestations and indirect effects on the eye. J Ophthalmol 2020;2020:4827304.
Sen M, Honavar SG, Sharma N, Sachdev MS. COVID-19 and eye: A review of ophthalmic manifestations of COVID-19. Indian J Ophthalmol 2021;69:488–509.
Kumar KK, Sampritha UC, Prakash AA, Adappa K, Chandraprabha S, Neeraja TG, et al. Ophthalmic manifestations in the COVID-19 clinical spectrum. Indian J Ophthalmol 2021;69:691–4.
Douglas KA, Douglas VP, Moschos MM. Ocular manifestations of COVID-19 (SARS-CoV-2): A critical review of current literature. In Vivo 2020;34 (3 Suppl):1619–28.
Goyal M, Murthy SI, Annum S. Retinal manifestations in patients following COVID-19 infection: A consecutive case series. Indian J Ophthalmol 2021;69:1275–82.
Shah KK, Venkatramani D, Majumder PD. A case series of presumed fungal endogenous endophthalmitis in post COVID-19 patients. Indian J Ophthalmol 2021;69:1322–5.
Shroff D, Narula R, Atri N, Chakravarti A, Gandhi A, Sapra N, et al. Endogenous fungal endophthalmitis following intensive corticosteroid therapy in severe COVID‐19 disease. Indian J Ophthalmol 2021;69:109–14.
Lingappan A, Wykoff CC, Albini TA, Miller D, Pathengay A, Davis JL, et al. Endogenous fungal endophthalmitis: Causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol 2012;153:162–6.
Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, et al. SARS‐CoV‐2 and viral sepsis: Observations and hypotheses. Lancet 2020;395:1517–20.
Bilgic A, Sudhalkar A, Gonzalez-Cortes JH, de Ribot FM, Yogi R, Kodjikian L, et al. Endogenous endophthalmitis in the setting of COVID-19 infection: A case series. Retina 2021;41:1709–14.
Agarwal M, Sachdeva M, Pal S, Shah H, Kumar RM, Banker A. Endogenous endophthalmitis a complication of COVID-19 pandemic: A case series. Ocul Immunol Inflamm 2021;29:726–9.
Fekri S, Khorshidifar M, Esfahanian F, Veisi A, Nouri H, Abtahi SH. Endogenous fungal endophthalmitis following COVID-19 hospitalization: Evidence from a year-long observational study. J Fr Ophtalmol 2023;46:461–7.
Sahu ES, Lahoti K, Bhargava A, Subhedar V, Sahu A. Subretinal aspergillus abscess in post COVID-19 recovered patients–An emerging problem. Ocul Immunol Inflamm 2023;31:127–33.
Mohan S, Kandle K, Ganesan S, Prakash VJ, Mistry S, Anand AR, et al. Endogenous fungal endophthalmitis following COVID-19 infection with microbiological and molecular biological correlation–A report of two cases. Indian J Ophthalmol 2023;71:2272–5.
Crane AB, Abreu Diaz MC, Jiang Y, Pergament KM. Rare case of endogenous Klebsiella endophthalmitis associated with emphysematous prostatitis in a patient with diabetes, cirrhosis and COVID-19. BMJ Case Rep 2021;14:e240425.
Markan A, Dogra M, Katoch D, Tomar M, Mittal H, Singh R. Endogenous endophthalmitis in COVID-19 patients: A case series and literature review. Ocul Immunol Inflamm 2023;31:1191–7.
Bhagali R, Prabhudesai NP, Prabhudesai MN. Post COVID-19 opportunistic candida retinitis: A case report. Indian J Ophthalmol 2021;69:987–9.
Eiden C, Peyrière H, Cociglio M, Djezzar S, Hansel S, Blayac JP, et al. Adverse effects of voriconazole: Analysis of the French Pharmacovigilance Database. Ann Pharmacother 2007;41:755–63.